Two Sigma Investments’s ABVC BioPharma ABVC Stock Holding History

Two Sigma Investments’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,210	Closed	-$11.5K	–	2929
2023 Q2	$11.5K	Sell	2,210 -280	-11%	-$1.86K	﹤0.01%	2940
2023 Q1	$15.9K	Buy	+2,490	New	+$17.8K	﹤0.01%	2864

Other funds holding ABVC

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments's ABVC Position: Q3 2023 in Review

Two Sigma Investments sold out of ABVC BioPharma (ABVC) in Q3 2023, closing a stake of 2,210 shares — an estimated $11.5K sold.

Two Sigma Investments first reported a position in ABVC in Q1 2023 and held it in 2 quarters. The position peaked at $15.9K in Q1 2023. 9 funds tracked by Wall St. Rank hold ABVC as of Q3 2023.

Two Sigma Investments reported no remaining ABVC BioPharma position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 2,210 ABVC BioPharma shares in Q3 2023, an estimated $11.5K.
Two Sigma Investments first reported a position in ABVC BioPharma in Q1 2023 and held it in 2 quarters.
Two Sigma Investments's ABVC BioPharma position peaked at $15.9K in Q1 2023.
9 funds tracked by Wall St. Rank held ABVC BioPharma as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.